Global rules for pharmaceutical products
Since February 2019, the European directive on falsified medicines (FMD) requires laboratories and pharmacies to ensure the serialization of medicines. The aim is to set up a system for verifying the authenticity of products, a system that consists of affixing a unique identifier to each box of medicines which will then be recorded in a central database. Traceability to the box” should make it possible to combat counterfeiting and parallel markets.
To meet the global requirements on pharmaceutical serialization, we provide you with a summary by country in a few words
